Marsh (MRSH) To Report Earnings Tomorrow: Here Is What To Expect

Marsh (NYSE: MRSH) will report earnings Tuesday before the bell. Last quarter, it posted revenue of $7.60B, up 7.6% YoY, and beat analysts on revenue and EPS. This quarter, analysts expect revenue growth of 4.3% YoY. Marsh’s shares are up 13.4% over the past month, with an average price target of $200.52 versus $181.60.

Original reporting
Published Jul 20, 2026, 4:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 20, 2026, 4:20 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Marsh (MRSH) To Report Earnings Tomorrow: Here Is What To Expect — source image
Decision brief

The 30-second read

$MRSHNeutralLow
01

Why it matters

Traders can use the timing and consensus framing to position for earnings volatility, but the article does not introduce new disclosures that would materially change the earnings setup.

02

Market read

Earnings timing and consensus expectations are the only actionable elements; no new guidance or surprise catalyst is disclosed.

03

What to watch

The article does not discuss margins, guidance, or deal pipeline specifics, which are typically the key drivers of post-earnings repricing.

Relevance 4/10Novelty 3/10Timing: ahead of Tuesday pre-bell earnings

Background

The piece is a pre-earnings preview for Marsh, referencing last quarter’s reported revenue/EPS beats and the current consensus revenue growth rate.

Company-level read

Ticker impact

$MRSHNeutralMedium confidence
Context

Marsh (MRSH) is set to report earnings Tuesday before the bell, with the article citing recent revenue/EPS beats and current consensus growth expectations.

Expected impact

Likely volatility around the open, with direction dependent on whether revenue growth re-accelerates versus the cited 4.3% expectation and whether organic/EPS beats persist.

Evidence & confidence

The newest concrete facts are the timing of the print and the stated consensus and prior-quarter figures; there is no fresh company-specific disclosure (guidance, revisions, or a new event) in the text.

Market effects

Provides a read-through setup for professional services earnings season, but without new sector data or guidance changes.

None stated.

None stated.

Counterpoint

If Marsh has missed revenue estimates multiple times over two years (as stated), the market may already be pricing in a beat, raising downside risk if results merely meet expectations.

Key entities

  • Marsh

    Professional services firm reporting earnings Tuesday before the bell; article cites prior-quarter revenue beat and current consensus growth expectations.

Related articles

$MRSHMed

Marsh & McLennan Companies Q2 Earnings Call Highlights

Marsh & McLennan (NYSE:MRSH) reported Q2 results and discussed market conditions on its earnings call. Consulting revenue rose 10% to $2.6B, with adjusted operating income up 11% to $533M. Mercer revenue was $1.6B. Marsh Global Insurance Market Index showed primary commercial rates down 6% in Q2. The company ended with $20.6B debt and $1.7B cash, and expects $5.5B capital deployment in 2026.

$MRSHMed

Marsh (NYSE:MRSH) Exceeds Q2 CY2026 Expectations

Marsh (NYSE:MRSH) reported Q2 CY2026 results. Revenue rose 6.2% year on year to $7.40 billion, exceeding Wall Street’s estimate by 1.8%, and non-GAAP EPS was $2.96, 2.3% above consensus. Adjusted operating margin was 26.9%. Analysts expect revenue growth of 4.2% and full-year EPS to rise from $10.22 to $10.90.

$MRSHMed

MARSH & MCLENNAN COMPANIES, INC. (MRSH): Results of Operations and Financial Condition

MARSH & MCLENNAN COMPANIES, INC. (MRSH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mmc2q2026ex991newsrelease.htm PRESS RELEASE JUNE 30, 2026 Document Marsh 212 345 5000 www.corporate.marsh.com News release Exhibit 99.1 Marsh reports second quarter 2026 results • Revenue Growth of 6%; Underlying Revenue Growth of 5% • GAAP Operating Income Increases 4%

$MRSHHighAI 9/10

Marsh & McLennan Companies (NYSE:MRSH) Stock Price Down 13.1% After Analyst Downgrade

Marsh & McLennan (NYSE:MRSH) fell 13.1% mid-day Wednesday after Piper Sandler cut its price target to $182 from $190 and kept a neutral rating. Shares traded as low as $180.97 and last at $160.70, after closing $185.00; volume rose to 3.04M. The article also cites recent analyst target changes and April 16 quarterly results: $3.29 EPS vs $3.21 consensus on $7.30B revenue.